Ivan Ischenko
- Oncology top 5%
- Cancer Cells and Metastasis 8
- Pancreatic and Hepatic Oncology Research 5
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 3
- Biotechnology top 5%
- Cancer Research and Treatments 2
- Genetics top 10%
-
- PI3K/AKT/mTOR signaling in cancer 5
- Angiogenesis and VEGF in Cancer 4
- Epigenetics and DNA Methylation 2
-
- Cancer Mechanisms and Therapy 4
- Co-authors
- Christiane J. BrunsKarl‐Walter JauchHendrik SeeligerMartin EichhornPeter ČamajAxel KleespiesMarkus GubaA. Papyan
- Cited by
- OncologyCancer ResearchBiotechnology
- Journals
- Targeted Oncology (2 papers)International Journal of Cancer (2 papers)Cancer Research (1 paper)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Ivan Ischenko
22 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 83
- Oncology 507
- Cancer Research 269
- Biotechnology 98
- Genetics 117
- Molecular Biology 621
Countries citing papers authored by Ivan Ischenko
This map shows the geographic impact of Ivan Ischenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Ischenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Ischenko more than expected).
Fields of papers citing papers by Ivan Ischenko
This network shows the impact of papers produced by Ivan Ischenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Ischenko. The network helps show where Ivan Ischenko may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ivan Ischenko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 84 | |
| 2 | 2014 | 43 | |
| 3 | 2011 | 74 | |
| 4 | 2010 | 19 | |
| 5 | 2010 | 82 | |
| 6 | 2009 | 68 | |
| 7 | 2009 | 40 | |
| 8 | 2009 | 123 | |
| 9 | 2009 | 11 | |
| 10 | 2009 | 69 | |
| 11 | 2009 | 75 | |
| 12 | 2008 | 71 | |
| 13 | 2008 | 60 | |
| 14 | 2008 | 10 | |
| 15 | 2008 | 31 | |
| 16 | 2007 | 44 | |
| 17 | 2007 | 25 | |
| 18 | 2007 | 59 | |
| 19 | 2005 | 33 | |
| 20 | 2005 | 109 |
About Ivan Ischenko
Ivan Ischenko is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 22 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (8 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Pancreatic and Hepatic Oncology Research (5 papers), Cancer Mechanisms and Therapy (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer Research and Treatments (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Oncology (507 citations), Cancer Research (269 citations) and Biotechnology (98 citations). Ivan Ischenko has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Christiane J. Bruns, Karl‐Walter Jauch, Hendrik Seeliger, Martin Eichhorn, Peter Čamaj, Axel Kleespies, Markus Guba, A. Papyan, Christian Graeb and Hanno Nieß. Their work appears in journals such as Targeted Oncology, International Journal of Cancer, Cancer Research, Journal of Cellular Biochemistry and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.